MCL1 and neuroblastoma: PI3K/Akt signaling is involved in Mcl-1 induction [10], targeting this pathway by newly developed PI3K inhibitor PI103 is showed to suppress Mcl-1 and induced apoptosis and restore sensitivity to TRAIL-induced apoptosis in neuroblastoma [45].